193 related articles for article (PubMed ID: 10935479)
1. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.
Mai S; Hanley-Hyde J; Rainey GJ; Kuschak TI; Paul JT; Littlewood TD; Mischak H; Stevens LM; Henderson DW; Mushinski JF
Neoplasia; 1999 Aug; 1(3):241-52. PubMed ID: 10935479
[TBL] [Abstract][Full Text] [Related]
2. Myc-induced cyclin D2 genomic instability in murine B cell neoplasms.
Mushinski JF; Hanley-Hyde J; Rainey GJ; Kuschak TI; Taylor C; Fluri M; Stevens LM; Henderson DW; Mai S
Curr Top Microbiol Immunol; 1999; 246():183-9; discussion 190-2. PubMed ID: 10396055
[No Abstract] [Full Text] [Related]
3. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
4. FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.
Dongsong N; Zhou JY
Mol Biol Rep; 2010 Oct; 37(7):3473-80. PubMed ID: 19967453
[TBL] [Abstract][Full Text] [Related]
5. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
6. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma.
Shapiro DN; Valentine MB; Rowe ST; Sinclair AE; Sublett JE; Roberts WM; Look AT
Am J Pathol; 1993 May; 142(5):1339-46. PubMed ID: 7684192
[TBL] [Abstract][Full Text] [Related]
7. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells.
Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N
Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406
[TBL] [Abstract][Full Text] [Related]
8. The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.
Kuschak TI; Taylor C; McMillan-Ward E; Israels S; Henderson DW; Mushinski JF; Wright JA; Mai S
Gene; 1999 Oct; 238(2):351-65. PubMed ID: 10570963
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin D2 in chronic B-cell malignancies.
Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
[TBL] [Abstract][Full Text] [Related]
12. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
13. Amplified extrachromosomal elements containing c-Myc and Pvt 1 in a mouse plasmacytoma.
Mai S; Hanley-Hyde J; Coleman A; Siwarski D; Huppi K
Genome; 1995 Aug; 38(4):780-5. PubMed ID: 7672608
[TBL] [Abstract][Full Text] [Related]
14. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines.
Khaira P; James CD; Leffak M
Gene; 1998 Apr; 211(1):101-8. PubMed ID: 9643977
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
[TBL] [Abstract][Full Text] [Related]
17. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
18. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.
Bouchard C; Thieke K; Maier A; Saffrich R; Hanley-Hyde J; Ansorge W; Reed S; Sicinski P; Bartek J; Eilers M
EMBO J; 1999 Oct; 18(19):5321-33. PubMed ID: 10508165
[TBL] [Abstract][Full Text] [Related]
19. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.
Palmero I; Holder A; Sinclair AJ; Dickson C; Peters G
Oncogene; 1993 Apr; 8(4):1049-54. PubMed ID: 8455931
[TBL] [Abstract][Full Text] [Related]
20. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
